Nasdaq

AC Immune Demonstrates Enhanced Performance of First-in-class Parkinson’s Diagnostic Agent

Oral presentation at AAIC further demonstrates the strength of AC Immune’s Morphomer™ platform for generating highly selective small molecule diagnostics LAUSANNE, Switzerland, July 28, 2020 (GLOBE ...
Nasdaq

AC Immune Presents New Preclinical Data for Therapeutic and Diagnostic Candidates ...

LAUSANNE, Switzerland, March 09, 2021 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative ...